Mei-Yin Polley to Neoplasm Grading
This is a "connection" page, showing publications Mei-Yin Polley has written about Neoplasm Grading.
Connection Strength
0.062
-
Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance). Cancer. 2019 10 01; 125(19):3378-3389.
Score: 0.039
-
Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol. 2012 Jan; 106(2):367-75.
Score: 0.023